4Aimee K. Bence,Eric B. Anderson,Maqbool A. Halepota,Michael A. Doukas,Phillip A. DeSimone,George A. Davis,Deborah A. Smith,Kevin M. Koch,Andrew G. Stead,Steve Mangum,Carolyn J. Bowen,Neil L. Spector,Showchien Hsieh,Val R. Adams. Phase I pharmacokinetic studies evaluating single and multiple doses of oral GW572016, a dual EGFR-ErbB2 inhibitor, in healthy subjects[J] 2005,Investigational New Drugs(1):39～49
